Skip to content

MGX - Metagenomi Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchM

Metagenomi, Inc. Common Stock

MGX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

M

MGXMetagenomi, Inc. Common Stock

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $3.95
52-wk low: $1.13
Prev close: $2.77
Mkt cap: $46.8M
Beta: 0.67
P/S: 3.5x

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$2.3M

JS
Jim Simons
Q2 2026 13F
$883K
position
TS
Two Sigma
Q2 2026 13F

Earnings

Reported Aug 10, 2026

Earnings came in 15.9% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $47M

Valuation

P/S3.45
P/B0.41

Quality

Operating margin11196.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: MGX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $46.84M
Beta: 0.67

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

0.4x

Profit margin

+0.0%

Op margin

+11196.0%

ROE

-60.6%

$611K

position

MI

Millennium

Israel Englander · Q2 2026 13F

$136K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for MGX

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.73-15.9%

-$0.63 expected

Next report

What the street expects next

-60.6%

ROA-28.2%

Growth

Beta0.67